Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse drug reactions: back to the future.

Literature DB >> 12755814

Adverse drug reactions: back to the future.

Munir Pirmohamed¹, B Kevin Park.

Abstract

Mesh：

Substances：

Year: 2003 PMID： 12755814 PMCID： PMC1884203 DOI： 10.1046/j.1365-2125.2003.01847.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

59 in total

1. The MedWatch Program.

Authors: L Love; M P Couig
Journal: J Toxicol Clin Toxicol Date: 1999

2. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study.

Authors: C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal: J Clin Pharm Ther Date: 2000-10 Impact factor: 2.512

3. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.

Authors: M Kvasz; I E Allen; M J Gordon; E Y Ro; R Estok; I Olkin; S D Ross
Journal: MedGenMed Date: 2000-04-27

Review 4. Genetic susceptibility to adverse drug reactions.

Authors: M Pirmohamed; B K Park
Journal: Trends Pharmacol Sci Date: 2001-06 Impact factor: 14.819

Review 5. Allergic reactions to drugs: involvement of T cells.

Authors: W J Pichler; N Yawalkar
Journal: Thorax Date: 2000-10 Impact factor: 9.139

6. The safety of newly approved medicines: do recent market removals mean there is a problem?

Authors: M A Friedman; J Woodcock; M M Lumpkin; J E Shuren; A E Hass; L J Thompson
Journal: JAMA Date: 1999-05-12 Impact factor: 56.272

7. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

Authors: M Pirmohamed; K Lin; D Chadwick; B K Park
Journal: Neurology Date: 2001-04-10 Impact factor: 9.910

8. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors: F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal: JAMA Date: 2000-09-13 Impact factor: 56.272

9. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors: C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal: N Engl J Med Date: 2000-11-23 Impact factor: 91.245

Review 10. Antiretroviral therapy and the lipodystrophy syndrome.

Authors: M John; D Nolan; S Mallal
Journal: Antivir Ther Date: 2001-03

11 in total

1. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

Authors: Tai-Yin Wu; Min-Hua Jen; Alex Bottle; Mariam Molokhia; Paul Aylin; Derek Bell; Azeem Majeed
Journal: J R Soc Med Date: 2010-06 Impact factor: 5.344

2. Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

Authors: Manfred Hauben; Stephen Bai; Eric Hung; Kasia Lobello; Charles Tressler; Vincent P Zucal
Journal: Eur J Clin Pharmacol Date: 2021-01-07 Impact factor: 2.953

Adverse drug reactions: back to the future.

1. The MedWatch Program.

2. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study.

3. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.

Review 4. Genetic susceptibility to adverse drug reactions.

Review 5. Allergic reactions to drugs: involvement of T cells.

6. The safety of newly approved medicines: do recent market removals mean there is a problem?

7. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.

8. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

9. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Review 10. Antiretroviral therapy and the lipodystrophy syndrome.

1. Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

2. Maternal paracetamol intake and fetal ductus arteriosus constriction/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria.

3. Using primary care prescribing databases for pharmacovigilance.

Review 4. Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

5. Drug allergy.

Review 6. Topical promethazine side effects: our experience and review of the literature.

7. The effects of distraction on symptoms during drug provocation test.

8. Clinical factors predicting drug-induced liver injury due to flucloxacillin.

Review 9. Non-psychotropic medication and risk of suicide or attempted suicide: a systematic review.

10. The 10-D assessment and evidence-based medicine tool for authors and peer reviewers in clinical pharmacology .